Friday, August 21, 2026
20.9 C
Bengaluru

7 Transitions in Leadership for Indian Pharma Leaders

The rapid pace of change, which began in 2020 is unrelenting and ongoing. The high-stakes game has made many pharma leaders play defensive, instead of using the crisis to bring in the much-needed transformational changes.

Leaders continue to rely on the traditional time-tested strategies, so that they can avoid the embarrassment of ‘losing’ in this high-stakes game. Most prefer to keep doing something they know to do well. We all like to do what we are good at, and are comfortable with. Most leaders are happy to be ‘nest-building’ and remain in their comfort zones.

There are several research findings, suggesting that to make the transition successfully, leaders must navigate a tricky set of changes in their leadership focus and skills.

Here are the seven shifts that leaders must understand and adapt:

  1. Move from, Specialist to Generalist
  2. Analyst to Integrator
  3. Tactician to Strategist
  4. Bricklayer to Architect
  5. Problem solver to Agenda setter
  6. Warrior to Diplomat, and 
  7. Supporting cast member to the Lead role

Digital Excellence Pharma Academy – DEPA, a joint initiative of CredoWeb and MedicinMan has put together 4 learning modules that will enable pharma professionals to be successful in the New Normal.

Register now on https://www.credoweb.in/discussion/588/7-role-transitions-for-pharma-leaders-key-lessons-from-sanjiv-navangul to listen Deep Bhandari explain the 7 Transitions in Leaders and the Key Lessons from Sanjiv Navangul’s session.

Hot this week

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Topics

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img